|
 |
Entocort ECThis page contains recent news articles, when available, and an overview of Entocort EC but does not offer medical advice. You should contact your physician with regard to any health issues or concerns.Overview: Entocort EC (when available) Budesonide is a synthetic corticosteroid indicated for the treatment of mild to moderate active Crohn's disease involving the ileum and/or the ascending colon. Budesonide is used in Crohn's disease to decrease the symptoms and inflammation associated with the disease, especially at times of flare up. Budesonide has a high topical glucocorticosteroid (GCS) activity and a substantial first pass elimination. The formulation contains granules which are coated to protect dissolution in gastric juice, but which dissolve at pH >5.5, ie, normally when the granules reach the duodenum. Thereafter, a matrix of ethylcellulose with budesonide controls the release of the drug into the intestinal lumen in a time-dependent manner. For the treatment of mild to moderate active Crohn's disease. Mechanism Of Action: The exact mechanism of action of budesonide in the treatment of Crohn's disease is not fully understood. However, being a glucocorticosteroid, budesonide has a high local anti-inflammatory effect. News Articles on Budesonide Entocort EC.(Drug overview) - Dec 1, 2005 Entocort EC is used to treat Crohn's disease, a chronic intestinal inflammation that causes sustained diarrhea and abdominal pain. ... Free with registration - PDR Family Guide to Prescription Drugs - AccessMyLibrary.com AGA Recommends ENTOCORT® EC Capsules as First-Line Therapy for … - Jun 6, 2006 1 ENTOCORT EC is a non-systemic glucocorticosteroid and is the only ... Because ENTOCORT EC has low systemic bioavailability, it has reduced side effects ... EndoNurse ENTOCORT(R) EC (Budesonide) Capsules Recommended By the … - Jun 5, 2006 1) ENTOCORT EC is a non-systemic glucocorticosteroid and is the only ... Because ENTOCORT EC has low systemic bioavailability, it has reduced side effects ... RedOrbit Prometheus Launches ENTOCORT(R) EC (Budesonide) Capsules - Jan 11, 2005 ..."ENTOCORT EC is a very important product for physicians and patients, ... The addition of ENTOCORT EC to our portfolio is also an important step in ... RedOrbit Prometheus Announces FDA Approval for Additional Indication of … - May 10, 2005 Entocort EC is the only pharmacological product indicated for the treatment of ... "We are excited to have this additional indication for Entocort EC," said ... RedOrbit Crohn Disease; Specialty pharma compny announces Entocort EC … - Jan 1, 2005 Entocort EC is the only US Food and Drug Administration (FDA)-approved drug indicated for the treatment of mild to moderate active Crohn disease involving ... Pay-Per-View - Obesity, Fitness & Wellness Week - Factiva, from Dow Jones Press Release: ENTOCORT(R) EC (budesonide) Capsules … - Jun 5, 2006 1) ENTOCORT EC is a non-systemic glucocorticosteroid and is the only ... Because ENTOCORT EC has low systemic bioavailability, it has reduced side effects ... Pay-Per-View - PR Newswire - HighBeam Research Press Release: Prometheus Launches ENTOCORT(R) EC (budesonide) … - Jan 11, 2005 ..."ENTOCORT EC is a very important product for physicians and patients, ... The addition of ENTOCORT EC to our portfolio is also an important step in ... Pay-Per-View - PR Newswire - HighBeam Research … Disease; Specialty pharmaceutical company launches ENTOCORT EC … - Feb 7, 2005 Shores continued, "ENTOCORT EC is a very important product for physicians and ... The addition of ENTOCORT EC to our portfolio is also an important step in ... Pay-Per-View - Gastroenterology Week - Factiva, from Dow Jones … Inc. Specialty pharmaceutical company launches ENTOCORT EC … - Feb 9, 2005 Shores continued, "ENTOCORT EC is a very important product for physicians and ... The addition of ENTOCORT EC to our portfolio is also an important step in ... Pay-Per-View - Biotech Week - Factiva, from Dow Jones Press Release: Prometheus Highlights Performance in 2006. - PR … - Apr 12, 2007 2) - Prometheus increased ENTOCORT EC net sales almost three-fold since the ... ENTOCORT EC total prescriptions increased approximately 42 in 2006 over 2004 ... Pay-Per-View - PR Newswire - HighBeam Research Press Release: Prometheus Announces FDA Approval for Additional … - May 10, 2005 Entocort EC is the only pharmacological product indicated for the treatment of mild to moderate ... Article: Specialty pharma compny announces Entocort EC . ... Pay-Per-View - PR Newswire - HighBeam Research Barr (BRL) Confirms Patent Challenge of Entocort(R), 3mg Enteric... - May 27, 2008 Entocort EC (budesonide) had annual sales of approximately $125 million in the US, based on IMS sales data for the twelve-month period ending March 2008. StreetInsider.com - StreetInsider.com (subscription) Prometheus Highlights Performance in 2006. - Apr 12, 2007 2) - Prometheus increased ENTOCORT EC net sales almost three-fold since the ... ENTOCORT EC total prescriptions increased approximately 42% in 2006 over ... $4.95 - PR Newswire - ECNext Prometheus Highlights Significant Milestones in 2005. - Apr 12, 2006 ENTOCORT EC net sales increased from approximately $30 million under ... ENTOCORT EC total prescriptions increased approximately 12% from 2004 to 2005, ... $4.95 - PR Newswire - ECNext Press Release: Barr Confirms Patent Challenge of Entocort(R), 3mg … - May 27, 2008 Entocort EC (budesonide) had annual sales of approximately $125 million in the U.S., based on IMS sales data for the twelve-month period ending March 2008. ... Pay-Per-View - PR Newswire - HighBeam Research Press Release: Prometheus Highlights Significant Milestones in 2005. ... - Apr 12, 2006 Entocort EC is the only ... AstraZeneca launched Entocort EC Capsules in ... effects of Entocort EC observed in ... Prometheus Prometheus Laboratories Inc. ... Pay-Per-View - PR Newswire - HighBeam Research Barr confirms Entocort patent challenge. - Jun 2, 2008 Entocort EC had annual sales of around $125.0 million in the USA, based on IMS Health sales data for the 12-month period ending March 2008. ... $9.94 - Pharma Marketletter - Alacra Store FDA DRUG APPROVALS Pictures from December 30, 2007 | HighBeam … - Dec 30, 2007 Entocort EC Budesonide capsules ASTRAZENECA Oral form of corticosteroid for Tx of mild to moderate Crohn's disease Budesonide has been approved in a new ... Pay-Per-View - AP Images - HighBeam Research … Ñ?удитÑ?Ñ? Ñ? Barr в отношении аналога препарата Entocort EC - May 28, 2007 Как Ñ?ообщает интернет-журнал Delawareonline, шведÑ?ко-британÑ?каÑ? фармацевтичеÑ?каÑ? компаниÑ? AstraZeneca направила в федеральный Ñ?уд г. ... ФармацевтичеÑ?кий веÑ?тник … Ñ?удитÑ?Ñ? Ñ? Barr в отношении аналога препарата Entocort EC - May 28, 2008 Как Ñ?ообщает интернет-журнал Delawareonline, шведÑ?ко-британÑ?каÑ? фармацевтичеÑ?каÑ? компаниÑ? AstraZeneca направила в федеральный Ñ?уд г. ... ФармацевтичеÑ?кий веÑ?тник New indications.(Rx)(restless legs syndrome can be cured by … - Jun 6, 2005 Prometheus Laboratories, San Diego, (888) 423-5227, has approval for an additional indication for Entocort EC (budesonide) Capsules. ... Free with registration - Drug Topics - AccessMyLibrary.com Web company gives prescription for competition: Site allows consumers... - May 23, 2007 When it came time to refill John Broderick's Entocort EC prescription, Laura decided to compare prices. What she found was a $120 price difference among ... Free with registration - Milwaukee Journal Sentinel - AccessMyLibrary.com Corticosteroids for inflammatory bowel disease - Oct 9, 2008 Budesonide (Entocort EC), a corticosteroid you take as a pill, affects only the intestinal tract. Because of this, it may cause fewer side effects than ... WebMD British Energy, Burberry, BSS, DCC: UK, Irish Equity Preview - May 27, 2008 AstraZeneca Plc (AZN LN): AstraZeneca sued Barr Pharmaceuticals Inc. to prevent it from selling a generic version of the drug Entocort EC, used to treat ... Bloomberg Influence of CYP3A4, CYP3A5, and ABCB1 Genotype and Expression on … - Apr 5, 2007 Edsbacker, S. & Andersson, T. Pharmacokinetics of budesonide (Entocort EC) capsules for Crohn's disease. Clin. Pharmacokinet. 43, 803–821 (2004). ... Nature.com Crohn's disease - Aug 10, 2005 A newer type of corticosteroid, budesonide (Entocort EC), is metabolized faster than traditional steroids and appears to produce fewer side effects. ... cnn.com Low-volume centers doing EC-IC bypass.(Cardiovascular Medicine)( … - Mar 1, 2005 Article: Entocort EC. (New & Approved). Internal Medicine News; November 15, 2001 ; 649 words ...(budesonide, AstraZeneca) An oral corticosteroid for mild ... Pay-Per-View - Internal Medicine News - HighBeam Research Southern Illinoisan : Grapefruit: The drugs it can affect - Jan 4, 2005 Budesonide (Entocort EC). Buspirone (BuSpar). Caffeine (coffee, tea, colas). Calcium Blockers: felodipine (Plendil), nicardipine (Cardene), ... $2.95 - Southern Illinoisan - NewsBank Press Release: AstraZeneca Proposes Mandatory FDA Review of All … - Nov 1, 2005 In addition, with the FDA's approval of new drugs ... catalog list price at which AstraZeneca sells ENTOCORT EC capsules ... ... Pay-Per-View - PR Newswire - HighBeam Research Brand Names/Synonyms: Entocort EC is also known by the following brand names and/or synonymsBidien; Budeson; Budesonide; Budesonide, Pharma; BudesonideÊ; Cortivent; Desonide; Desowen; Entocort; Entocort Ec; Micronyl; Preferid; Pulmicort; Pulmicort Nebuamp; Pulmicort Respules; Pulmicort Turbuhaler; Rhinocort; Rhinocort Aqua; Rhinocort Turbuhaler; Spirocort; Tridesilon Drug Category: Entocort EC is categorized under the following by the FDA: Bronchodilator Agents; Anti-inflammatory Agents; Corticosteroids; ATC:A07EA06; ATC:D07AC09; ATC:R01AD05; ATC:R03BA02 Dosage Forms: CAPSULE (SUSTAINED-RELEASE); METERED-DOSE (AEROSOL); SUSPENSION Absorption: Complete Interactions: [an error occurred while processing this directive] Chemical IUPAC Name: Not Available |
|
Health Home | Conditions | Cancer | Medications | Surgery | Vaccines The Cancer News Network
COPYRIGHT 2009 CANCERNEWSNETWORK | Privacy |